论文部分内容阅读
目的 :探讨重组干扰素 α- 2 b治疗腮腺炎性睾丸炎疗效。方法 :98例流行性腮腺炎性睾丸炎的患者随机分为 A组和 B组 ,A组 47例 (年龄 2 2岁± 5岁 )采用常规治疗 ,B组 5 1例 (年龄 2 1岁± 4岁 )在常规治疗的基础上加用重组干扰素α- 2 b10万 u/(kg.d) ,肌肉注射 ,连用 35 d。结果 :B组总有效率 88.2 %与 A组 6 5 .9%比较差异有非常显著意义 (P<0 .0 1)。结论 :重组干扰素 α- 2 b治疗腮腺炎性睾丸炎的疗效好 ,且无明显副作用。
Objective: To investigate the therapeutic effect of recombinant interferon α-2b on mumps orchitis. Methods: A total of 98 patients with parotitis orchitis were randomly divided into group A and group B. Group A (n = 47) (age 22 ± 5) received routine treatment. Group B (n = 51) 4 years old) on the basis of conventional treatment with recombinant interferon α-2 b10 million u / (kg.d), intramuscular injection, once every 35 d. Results: The total effective rate in group B was 88.2%, which was significantly different from 65.9% in group A (P <0.01). Conclusion: Recombinant interferon α-2b treatment of mumps orchitis has good curative effect, and no obvious side effects.